147 related articles for article (PubMed ID: 10764846)
21. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
22. [Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].
Domke A; Willms B
Med Klin (Munich); 1994 Apr; 89(4):187-92. PubMed ID: 8015532
[TBL] [Abstract][Full Text] [Related]
23. New directions in type 2 diabetes mellitus: an update of current oral antidiabetic therapy.
Brown DL; Brillon D
J Natl Med Assoc; 1999 Jul; 91(7):389-95. PubMed ID: 10643211
[TBL] [Abstract][Full Text] [Related]
24. The development of an oral antidiabetic combination tablet: design, evaluation and clinical benefits for patients with type 2 diabetes.
Howlett H; Porte F; Allavoine T; Kuhn T; Nicholson G
Curr Med Res Opin; 2003; 19(3):218-25. PubMed ID: 12803736
[TBL] [Abstract][Full Text] [Related]
25. A comparison of costs for four oral antidiabetic regimens within a managed care population.
Stockl K; Vanderplas AM; Nicklasson L
Manag Care Interface; 2003 Jul; 16(7):31-6. PubMed ID: 12908215
[TBL] [Abstract][Full Text] [Related]
26. Optimising therapy for insulin-treated type 2 diabetes mellitus.
Hermann LS
Drugs Aging; 2000 Oct; 17(4):283-94. PubMed ID: 11087006
[TBL] [Abstract][Full Text] [Related]
27. Oral antidiabetic agents. A guide to selection.
Scheen AJ; Lefèbvre PJ
Drugs; 1998 Feb; 55(2):225-36. PubMed ID: 9506242
[TBL] [Abstract][Full Text] [Related]
28. Clinical inquiries. What is the role of combination therapy (insulin plus oral medication) in type 2 diabetes?
Eskesen S; Kelsberg G; Hitchcock K; Lo V
J Fam Pract; 2006 Nov; 55(11):1001-3. PubMed ID: 17090364
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacological recommendations in the daily metabolic control of diabetes mellitus type 2. The role of the new insulins].
Sánchez Sánchez O; Sabán Ruiz J
Rev Clin Esp; 2007 Sep; 207(8):411-5. PubMed ID: 17688872
[TBL] [Abstract][Full Text] [Related]
30. [Metformin--its regimen and effects].
Shiba T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():382-8. PubMed ID: 12387022
[No Abstract] [Full Text] [Related]
31. Oral pharmacologic management of type 2 diabetes.
Riddle MC
Am Fam Physician; 1999 Dec; 60(9):2613-20. PubMed ID: 10605995
[TBL] [Abstract][Full Text] [Related]
32. [Glinides and glitazones in diabetes treatment. Are they really effective?].
Parhofer KG; Göke B
MMW Fortschr Med; 2002 May; 144(18):34-6, 38-9. PubMed ID: 12422705
[TBL] [Abstract][Full Text] [Related]
33. [Could oral antidiabetic agents be useful in the management of different types of diabetes and syndromes of insulin resistance in children and adolescents?].
Otto-Buczkowska E; Nowowiejska B; Jarosz-Chobot P; Stańczyk J
Przegl Lek; 2009; 66(7):388-93. PubMed ID: 20043582
[TBL] [Abstract][Full Text] [Related]
34. [Exploring an optimal approach to the use of oral hypoglycemic agents based on CGM results: implications for combination therapy with oral hypoglycemic agents].
Mori Y
Nihon Rinsho; 2011 Aug; 69(8):1505-14. PubMed ID: 21838054
[TBL] [Abstract][Full Text] [Related]
35. Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients.
Ali Z; Daniyal M; S I I; Usmanghani K; Naveed S
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1443-9. PubMed ID: 27592478
[TBL] [Abstract][Full Text] [Related]
36. Treatment of diabetes mellitus: implications of the use of oral agents.
Rao SV; Bethel MA; Feinglos MN
Am Heart J; 1999 Nov; 138(5 Pt 1):S334-7. PubMed ID: 10539794
[No Abstract] [Full Text] [Related]
37. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients: response to Rosenstock et al.
Hamid Z; Simmons DL
Diabetes Care; 2006 Oct; 29(10):2331; author reply 2332. PubMed ID: 17003324
[No Abstract] [Full Text] [Related]
38. Type 2 diabetes: glycemic targets and oral therapies for older patients.
Lardinois CK
Geriatrics; 1998 Nov; 53(11):22-3, 27-8, 33-4 passim. PubMed ID: 9824974
[TBL] [Abstract][Full Text] [Related]
39. Oral combination therapy with thiazolidinediones in type 2 diabetes.
LaSalle JR; Cross LB
Am J Manag Care; 2006 Nov; 12(14 Suppl):S369-81. PubMed ID: 17112324
[TBL] [Abstract][Full Text] [Related]
40. New oral therapies for type 2 diabetes.
Purnell JQ; Hirsch IB
Am Fam Physician; 1997 Nov; 56(7):1835-42. PubMed ID: 9371013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]